Gene · 4210
NIH grants1,417
NIH projects whose papers are about the gene, through NIH's grant-paper links.
41 to 60 of 1,417
Download this page as JSON| Project | Title | Its papers about the gene | Newest fiscal year |
|---|---|---|---|
| R01AI155488 | Studies of a new checkpoint regulator in the control of intestinal inflammation | 2 | 2025 |
| R01AI158314 | Role and Mitigation of Inflammasomes and Inflammation During COVID-19 | 2 | 2025 |
| R01AI163029 | Inborn errors of immunity in patients with life-threatening COVID-19 | 2 | 2025 |
| R01GM102146 | Inflammasome activation in trauma-hemorrhagic shock | 2 | 2025 |
| R01GM105847 | Activities of nucleoprotein complexes visualized in single-molecule experiments | 2 | 2025 |
| R01GM108618 | Inflammation Phenotypes in Pediatric Sepsis Induced Multiple Organ Failure Renewal | 2 | 2025 |
| R01HL086694 | From GWAS loci to blood pressure genes, variants & mechanisms - Renewal | 2 | 2025 |
| R35CA232109 | Intracellular Innate Immune Receptors in Cancer Suppression and Immunotherapy | 2 | 2025 |
| R35GM145363 | Mechanistic Studies of cytosolic double-stranded DNA sensing pathways. | 2 | 2025 |
| T32AI007245 | Molecular Basis of Viral Infectivity | 2 | 2025 |
| T32HL007574 | Pathophysiology of Human Blood Cells | 2 | 2025 |
| U01DK062422 | Mount Sinai NYC Genetics Research Center: Multi-omic integration across data-types, cell niches and populations | 2 | 2025 |
| U01HG008680 | EHR-based Genome-Informed Risk Assessment and Communication | 2 | 2025 |
| ZIAAI001059 | Defining New Human Immunodeficiency and Immunodysregulation Disorders | 2 | 2025 |
| ZIAAR041170 | Studies of the Natural History of Rheumatic Diseases | 2 | 2025 |
| ZIAAR041198 | Genetics and pathophysiology of systemic juvenile idiopathic arthritis and other complex autoinflammatory diseases | 2 | 2025 |
| ZIACP010135 | Studies of Non-Ionizing Radiation-Related Cancer | 2 | 2025 |
| ZIAHG000030 | Mechanistic and translational studies of CBF leukemia | 2 | 2025 |
| ZICAR041173 | Applying Bioinformatics to Research in Immune, Muscle, and Bone Diseases | 2 | 2025 |
| ZICAR041181 | Translational Immunology research: a support for clinical immunological research | 2 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.1.0
Sources 11
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNone stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GeneNone named. Public domain as US government information
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4210/grants?page=3